These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 8782230

  • 1. Radiosynthesis of [11C]brofaromine, a potential tracer for imaging monoamine oxidase A.
    Ametamey SM, Beer HF, Guenther I, Antonini A, Leenders KL, Waldmeier PC, Schubiger PA.
    Nucl Med Biol; 1996 Apr; 23(3):229-34. PubMed ID: 8782230
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of neurochemical effects of the monoamine oxidase inhibitors phenelzine, moclobemide and brofaromine in the rat after short- and long-term administration.
    Urichuk LJ, Allison K, Holt A, Greenshaw AJ, Baker GB.
    J Affect Disord; 2000 May; 58(2):135-44. PubMed ID: 10781703
    [Abstract] [Full Text] [Related]

  • 6. Effect of the selective MAO-A inhibitors brofaromine, clorgyline and moclobemide on human platelet MAO-B activity.
    Gleiter CH, Nilsson E, Mühlbauer B, Antonin KH, Bieck PR.
    J Neural Transm Gen Sect; 1992 May; 89(1-2):129-33. PubMed ID: 1418864
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of monoamine oxidase-A inhibition by moclobemide in vitro and ex vivo in rats.
    Kettler R, Da Prada M, Burkard WP.
    Acta Psychiatr Scand Suppl; 1990 May; 360():101-2. PubMed ID: 2248058
    [Abstract] [Full Text] [Related]

  • 10. The advent of a new generation of monoamine oxidase inhibitor antidepressants: pharmacologic studies with moclobemide and brofaromine.
    Lavian G, Finberg JP, Youdim MB.
    Clin Neuropharmacol; 1993 May; 16 Suppl 2():S1-7. PubMed ID: 8313392
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and characterization of 11C-labeled fluoroclorgyline: a monoamine oxidase A specific inhibitor for positron emission tomography.
    Ohmomo Y, Hirata M, Murakami K, Magata Y, Tanaka C, Yokoyama A.
    Chem Pharm Bull (Tokyo); 1993 Nov; 41(11):1994-7. PubMed ID: 8293522
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Species differences in [11C]clorgyline binding in brain.
    Fowler JS, Ding YS, Logan J, MacGregor RR, Shea C, Garza V, Gimi R, Volkow ND, Wang GJ, Schlyer D, Ferrieri R, Gatley SJ, Alexoff D, Carter P, King P, Pappas N, Arnett CD.
    Nucl Med Biol; 2001 Oct; 28(7):779-85. PubMed ID: 11578898
    [Abstract] [Full Text] [Related]

  • 14. Newer aspects of the reversible inhibitor of MAO-A and serotonin reuptake, brofaromine.
    Waldmeier PC.
    Prog Neuropsychopharmacol Biol Psychiatry; 1993 Mar; 17(2):183-98. PubMed ID: 8430214
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and in vivo imaging properties of [11C]befloxatone: a novel highly potent positron emission tomography ligand for mono-amine oxidase-A.
    Dolle F, Valette H, Bramoulle Y, Guenther I, Fuseau C, Coulon C, Lartizien C, Jegham S, George P, Curet O, Pinquier JL, Bottlaender M.
    Bioorg Med Chem Lett; 2003 May 19; 13(10):1771-5. PubMed ID: 12729662
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Development of N-[3-(2',4'-dichlorophenoxy)-2-18F-fluoropropyl]-N-methylpropargylamine (18F-fluoroclorgyline) as a potential PET radiotracer for monoamine oxidase-A.
    Mukherjee J, Yang ZY.
    Nucl Med Biol; 1999 Aug 19; 26(6):619-25. PubMed ID: 10587099
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.